Ignite Creation Date:
2025-12-25 @ 3:15 AM
Ignite Modification Date:
2026-04-16 @ 4:13 PM
Study NCT ID:
NCT01722305
Status:
COMPLETED
Last Update Posted:
2019-07-22
First Post:
2012-11-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular Lymphoma
Sponsor:
Mayo Clinic
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-04-08
Start Date Type:
ACTUAL
Primary Completion Date:
2016-06-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-07-15
Completion Date Type:
ACTUAL
First Submit Date:
2012-11-02
First Submit QC Date:
None
Study First Post Date:
2012-11-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-18
Last Update Post Date:
2019-07-22
Last Update Post Date Type:
ACTUAL